Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial

Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial

(2022) Livingstone Tavul et al.   PLoS Neglected Tropical Diseases

An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India

(2021) Purushothaman Jambulingam et al.   PLoS Neglected Tropical Diseases

Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial

(2021) Myra Hardy et al.   CLINICAL INFECTIOUS DISEASES

An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia

(2021) Taniawati Supali et al.   PLoS Neglected Tropical Diseases

Single-Dose Triple-Drug Therapy for Wuchereria bancrofti — 5-Year Follow-up

(2020) Christopher L. King et al.   NEW ENGLAND JOURNAL OF MEDICINE

Decreased bioefficacy of long-lasting insecticidal nets and the resurgence of malaria in Papua New Guinea

(2020) Rebecca Vinit et al.   Nature Communications

Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study

(2020) Christine L. Dubray et al.   PLoS Neglected Tropical Diseases

Pharmacokinetic and safety study of co-administration of albendazole, diethylcarbamazine, Ivermectin and azithromycin for the integrated treatment of Neglected Tropical Diseases

(2020) Lucy N John et al.   CLINICAL INFECTIOUS DISEASES

The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study

(2019) Gary J. Weil et al.   PLOS MEDICINE

A Trial of a Triple-Drug Treatment for Lymphatic Filariasis

(2018) Christopher L. King et al.   NEW ENGLAND JOURNAL OF MEDICINE

Measurement of Circulating Filarial Antigen Levels in Human Blood with a Point-of-Care Test Strip and a Portable Spectrodensitometer

(2016) Cédric B. Chesnais et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis

(2015) Edward K. Thomsen et al.   CLINICAL INFECTIOUS DISEASES

Semi-Quantitative Scoring of an Immunochromatographic Test for Circulating Filarial Antigen

(2013) Cédric B. Chesnais et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Laboratory and Field Evaluation of a New Rapid Test for Detecting Wuchereria bancrofti Antigen in Human Blood

(2013) Gary J. Weil et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011

(2013) Patricia M Graves et al.   Parasites & Vectors

Role of Vector Control in the Global Program to Eliminate Lymphatic Filariasis

(2008) Moses J. Bockarie et al.   Annual Review of Entomology